Close Menu

NEW YORK (GenomeWeb) – Biomarkers predicting cancer drug response can be uncovered from omics data of patient samples as well as cell lines, according to a new study.

Investigators have previously had mixed results when trying to use cancer cell line profiling to test the function and therapeutic relevance of molecular alterations uncovered in tumor samples. According to a trio of University of California, San Francisco, researchers this, is in part due to differences between cell lines and the tumors they represent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.

Jun
13
Sponsored by
Roche

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
17
Sponsored by
Illumina

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.